These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 13268417)

  • 21. Studies on the potency test of BCG vaccine; studies on the inoculation of tubercle bacilli (or BCG) into the ocular anterior-chamber of rabbits. I. The inoculation of bacilli into the ocular anterior-chamber of rabbits for a virulence test of tubercle bacilli or a potency test of BCG vaccine.
    SAKAKI K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Jul; 7(1):75-96. PubMed ID: 13432807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Introduction to the experimental study of immunity and allergy in tuberculosis].
    RAMON G
    Rev Immunol Ther Antimicrob; 1951; 15(1-2):68-89. PubMed ID: 14865373
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative studies of anti-tuberculosis vaccination of guinea pigs with Mycobacterium tuberculosis var. muris and with BCG].
    GROSSO E
    Boll Ist Sieroter Milan; 1955; 34(11-12):712-20. PubMed ID: 13293258
    [No Abstract]   [Full Text] [Related]  

  • 24. [Utilization of radiocarbon-labeled bovine and human tubercle bacilli for the comparative study of the efficacy of freeze-dried BCG vaccines of different origins, injected by different routes].
    PASQUIER JF; KURYLOWICZ W
    C R Seances Soc Biol Fil; 1956; 150(2):281-4. PubMed ID: 13343653
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of the virulence and protective potency against tuberculous infection of vole bacillus, low-virulent human tubercle bacillus Imamura's strain, and BCG.
    TOSHIMA M
    Sci Rep Res Inst Tohoku Univ Med; 1952 Dec; 4(2):135-49. PubMed ID: 13064629
    [No Abstract]   [Full Text] [Related]  

  • 26. Ultraviolet susceptibility of BCG and virulent tubercle bacilli.
    Riley RL; Knight M; Middlebrook G
    Am Rev Respir Dis; 1976 Apr; 113(4):413-8. PubMed ID: 817628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental tuberculosis in non-vaccinated dogs and in dogs vaccinated with living (BCG) and dead (AIP, VPS and VDS) bacilli].
    SALVIOLI G; DEGLI ESPOSTI A; DINA MA
    Acta Tuberc Scand; 1953; 28(1-2):147-54. PubMed ID: 13079975
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allergy and immunity in spontaneous infection and BCG vaccination].
    WUNDERWALD A
    Zentralbl Allg Pathol; 1955 Sep; 94(3-4):196-9. PubMed ID: 13282425
    [No Abstract]   [Full Text] [Related]  

  • 29. ROUTES OF DISSEMINATION OF INTRANASALLY INSTILLED TUBERCLE BACILLI. AN EXPERIMENTAL STUDY.
    BURKE HE; MANKIEWICZ E
    Am Rev Respir Dis; 1963 Sep; 88():376-83. PubMed ID: 14064913
    [No Abstract]   [Full Text] [Related]  

  • 30. [Glycerokinases from Mycobacteria (BCG, H37Ra, M. phlei)].
    Andrejew A; Orfanelli MT; Desbordes J
    Biochimie; 1976; 58(11-12):1423-5. PubMed ID: 189849
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the potency test of BCG vaccine; studies on the inoculation of tubercle bacilli (or BCG) into the ocular anterior-chamber of rabbits. II. Determination of the protective effect of BCG vaccines by the challenge with virulent human tubercle bacilli into the ocular anterior-chamber of the immunized rabbits.
    SAKAKI K
    Sci Rep Res Inst Tohoku Univ Med; 1956 Jul; 7(1):97-113. PubMed ID: 13432808
    [No Abstract]   [Full Text] [Related]  

  • 32. Allergy and immunity in tuberculosis, with special reference to BCG vaccination.
    HOWARD WA
    Clin Proc Child Hosp Dist Columbia; 1949 Jul; 5(8):205-21. PubMed ID: 18135530
    [No Abstract]   [Full Text] [Related]  

  • 33. Serologic investigations of mycobacterial antigens. II. Specificities of antigens obtained by successive aqueous extraction of BCG and Mycobacterium phlei.
    THURSTON JR; RHEINS M
    Am Rev Tuberc; 1956 Apr; 73(4):571-5. PubMed ID: 13302687
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental study on airborne infection with tubercle bacilli, especially infection with the isoniazid-resistant strain and the relation of BCG immunity].
    SHIMOIDE H; TOYOHARA M
    Kekkaku; 1961 Nov; 36():727-32. PubMed ID: 13911991
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunity and tuberculosis].
    WALLGREN A
    Lotta Tuberc; 1952 Dec; 22(12):931-49. PubMed ID: 13053895
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunizing properties of an isoniazid-resistant mutant of the Vallée strain of M. tuberculosis as compared with BCG; observations in the mouse and guinea pig.
    HOBBY GL; LENERT TF; AUERBACH O
    Am Rev Tuberc; 1954 Sep; 70(3):527-30. PubMed ID: 13189070
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of different BCG vaccines by means of bovine and human tuberculosis bacilli labeled with C14 (14CH3CO2Na)].
    PASQUIER JF; KURYLOWICZ W
    Rev Immunol Ther Antimicrob; 1956; 20(3):139-60. PubMed ID: 13351062
    [No Abstract]   [Full Text] [Related]  

  • 39. IMMUNIZATION EXPERIMENTS ON RABBITS WITH HEXANE-TREATED, KILLED TUBERCLE BACILLI.
    VAHLNE G
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:47-53. PubMed ID: 14164136
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of allergy in tuberculosis and in BCG vaccination].
    RIBEIRO R
    J Med (Oporto); 1953 Jan; 21(520):125-30. PubMed ID: 13044436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.